Paxlovid keeping hospitalizations, deaths low as COVID-19 infections rise, White House official says
By
Alicia Lasek
May 19, 2022
Clinicians are writing 20,000 prescriptions for Paxlovid each day, helping to keep severe outcomes in check, the COVID-19 Response Coordinator said Wednesday.
Antiviral pill halts SARS-CoV-2 virus activity by day 3
By
Alicia Lasek
Apr 06, 2022
New results confirm that Merck’s molnupiravir clears the virus quickly, lowering the risk of progression to severe illness in at-risk patients, researchers report.
‘They heard us’: Partner program to allow fast LTC access to federal stock of COVID-19 drugs
By
Alicia Lasek
Mar 04, 2022
The federal Long-Term Care Partner Program aims to quickly get time-sensitive COVID-19 treatments to facilities when an outbreak occurs. The first drug available via the portal will be molnupiravir, followed...
Long-term care facilities to receive expedited meds under National COVID-19 Preparedness Plan
By
Alicia Lasek
Mar 03, 2022
Hundreds of facilities will be able to directly order COVID-19 antiviral drugs and receive direct distributions starting this month, federal officials say.
U.S. doubles order of Paxlovid antiviral pill to 20M
By
Alicia Lasek
Jan 05, 2022
The initial supply of the COVID-19 medication will be limited, and shipments to states will be spread out over time, “ramping up steadily in the months ahead,” according to the Department of Health...
FDA set to approve two COVID-19 antiviral pills this week
By
Alicia Lasek
Dec 22, 2021
FDA is expected to grant emergency use authorization to two antiviral COVID-19 pills this week, possibly as early as today, according to Bloomberg News, citing sources familiar with the matter.
Pfizer says final data show COVID-19 pill stays strong against severe illness
Dec 14, 2021
Latest results show that drug cuts hospitalizations, deaths by nearly 90 percent when taken within three to five days of the start of symptoms
